Ergospirometric Values and WBV in Elderly

Not Applicable

Completed

• Conditions: Aging

• Registration Number: NCT01681719
• Lead Sponsor: Maíra F Pessoa

Brief Summary

this study aims evaluate the ergospirometric values after 03 months of training with WBV in elderly health people. The hypothesis is increases of ergospirometric values.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Primary Completion: 2011-12
• Study First Submitted: 2012-08-30
• Status Verified: 2012-09
• Study First Submitted QC: 2012-09-05
• Last Update Submitted: 2012-09-05
• Study First Posted: 2012-09-10
• Last Update Posted: 2012-09-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• aged 60-74 years,
• Sedentary or Moderate A in accord with IPAQ short form (International Physical Activity Questionnaire) and those without disease.
• furthermore, the subjects should reach the ventilatory threshold 1, considered after meeting two of the following events:
• respiratory quotient (R) increases (R ≥1,1);
• loss of linearity between the pulmonary ventilation curve (VE) and oxygen consumption (VO2), plateau of VO2 or plateau of heart rate (HR) and increases of end-tidal PO2 (Pet O2)

Exclusion Criteria

• Were excluded subjects with changes in Mini-mental state examination (MMSE) scores by age and educational level where the minimum score represents: illiterate 13 points, less than 8 study years is 18 points, 8 or more study years is 26 points 11.
• Were also excluded current smokers or previous, subjects with thrombosis, labyrinthitis, diabetes, hemodynamic instabilities, obesity, osteoporosis, neuromuscular diseases, pulmonary or cardiac diseases, changes in resting electrocardiogram or in exercise, ingestion of drugs to metabolism bone / muscle / heart chronotropism or with difficulties in adapting protocols

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
maximal O2 consumption	started and finished the protocol after 03 months

Trial Locations

Locations (1)

UFPE; 🇧🇷 Recife, Pernambuco, Brazil